[{"id":"1d9df858-02f3-4502-906c-15d18a9ed9f8","acronym":"","url":"https://clinicaltrials.gov/study/NCT06494943","created_at":"2025-02-26T14:28:07.615Z","updated_at":"2025-02-26T14:28:07.615Z","phase":"Phase 1","brief_title":"Induction IBI110 and Sintilimab With Chemotherapy In LA HNSCC","source_id_and_acronym":"NCT06494943","lead_sponsor":"Fudan University","biomarkers":" TMB","pipe":"","alterations":" ","tags":["TMB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • Tyvyt (sintilimab) • negalstobart (IBI110)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 06/26/2024","start_date":" 06/26/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 12/31/2028","study_completion_date":" 12/31/2028","last_update_posted":"2024-07-10"}]